Selected Phytoestrogens Distinguish Roles of ERα Transactivation and Ligand Binding for Anti-Inflammatory Activity

Endocrinology. 2018 Sep 1;159(9):3351-3364. doi: 10.1210/en.2018-00275.

Abstract

Estrogen receptor α (ERα) is a ligand-activated transcriptional activator that is also involved vascular inflammation and atherosclerosis. Whether different ligands may affect this activity has not been explored. We screened a panel of phytoestrogens for their role in ERα binding and transcriptional transcription, and correlated the findings to anti-inflammatory activities in vascular endothelial cells stably expressing either a wild-type or mutant form of ERα deficient in its membrane association. Taxifolin and silymarin were "high binders" for ERα ligand binding; quercetin and curcumin were "high activators" for ERα transactivation. Using these phytoestrogens as functional probes, we found, in endothelial cells expressing wild-type ERα, the ERα high activator, but not the ERα high binder, promoted ERα nuclear translocation, estrogen response element (ERE) reporter activity, and the downstream gene expression. In endothelial cells expressing membrane association-deficient mutant ERα, the ERα nuclear translocation was significantly enhanced by taxifolin and silymarin, which still failed to activate ERα. Inflammation response was examined using the systemic or vascular inflammation inducers lipopolysaccharide or oxidized low-density lipoprotein. In both cases, only the ERα high activator inhibited nuclear translocation of nuclear factor κB, JNK, and p38, and the production of inflammatory cytokines IL-1β and TNFα. We confirm a threshold nuclear accumulation of ERα is necessary for its transactivation. The anti-inflammatory activity of phytoestrogens is highly dependent on ERα transactivation, less so on the ligand binding, and independent of its membrane association. A pre-examination of phytoestrogens for their mode of ERα interaction could facilitate their development as better targeted receptor modifiers.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / pharmacology*
  • Antioxidants / pharmacology*
  • Atherosclerosis / immunology
  • Cell Line
  • Curcumin / pharmacology
  • Endothelial Cells / drug effects*
  • Endothelial Cells / metabolism
  • Estrogen Receptor alpha / drug effects*
  • Estrogen Receptor alpha / genetics
  • Estrogen Receptor alpha / metabolism
  • Humans
  • Inflammation / immunology
  • Interleukin-1beta / drug effects
  • Interleukin-1beta / immunology
  • Ligands
  • Lipopolysaccharides / pharmacology
  • Lipoproteins, LDL / pharmacology
  • MAP Kinase Kinase 4 / drug effects
  • MAP Kinase Kinase 4 / immunology
  • Molecular Docking Simulation
  • Mutation
  • NF-kappa B / drug effects
  • NF-kappa B / immunology
  • Phytoestrogens / pharmacology*
  • Protein Transport
  • Quercetin / analogs & derivatives
  • Quercetin / pharmacology
  • Response Elements
  • Signal Transduction
  • Silymarin / pharmacology
  • Tumor Necrosis Factor-alpha / drug effects
  • Tumor Necrosis Factor-alpha / immunology
  • p38 Mitogen-Activated Protein Kinases / drug effects
  • p38 Mitogen-Activated Protein Kinases / immunology

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Antioxidants
  • ESR1 protein, human
  • Estrogen Receptor alpha
  • IL1B protein, human
  • Interleukin-1beta
  • Ligands
  • Lipopolysaccharides
  • Lipoproteins, LDL
  • NF-kappa B
  • Phytoestrogens
  • Silymarin
  • Tumor Necrosis Factor-alpha
  • oxidized low density lipoprotein
  • Quercetin
  • taxifolin
  • p38 Mitogen-Activated Protein Kinases
  • MAP Kinase Kinase 4
  • Curcumin